Cogent Biosciences (COGT) Institutional Ownership

During the previous two years, 115 institutional investors and hedge funds held shares of Cogent Biosciences. The most heavily invested institutionals were FMR LLC ($89.85M), Point72 Asset Management L.P. ($88.27M), RA Capital Management L.P. ($75.97M), TCG Crossover Management LLC ($66.67M), Commodore Capital LP ($65.90M), Kynam Capital Management LP ($57.12M), and VR Adviser LLC ($55.46M).Learn more on COGT's institutional investors.

Of the 95 institutional investors that purchased Cogent Biosciences stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Point72 Asset Management L.P. ($12.10M), Kynam Capital Management LP ($8.10M), FMR LLC ($4.87M), RA Capital Management L.P. ($2.40M), Deerfield Management Company L.P. Series C ($2.21M), Janus Henderson Group PLC ($2.08M), and TCG Crossover Management LLC ($2M).

Institutional investors have bought a total of 47,037,856 shares in the last 24 months. This purchase volume represents approximately $419.45M in transactions.

Of the 50 institutional investors that sold Cogent Biosciences stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Deerfield Management Company L.P. Series C ($2.28M), Eventide Asset Management LLC ($1.77M), Perceptive Advisors LLC ($1.19M), State Street Corp ($605.50K), Dimensional Fund Advisors LP ($463.90K), SG Americas Securities LLC ($426.40K), and Assenagon Asset Management S.A. ($387.87K).

Institutional investors have sold a total of 10,006,230 shares in the last 24 months. This volume of shares sold represents approximately $92.84M in transactions.